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Main goal: determine genetic variants inﬂuencing complex diseases
Genetic information is available through genetic markers such as
biallelic SNPs (International SNP Map Working Group 2001,
International Hapmap Consortium 2003, 2005, 2007)
Genetics eﬀects are often small and thus diﬃcult to detect
Genetic eﬀects often interact with environmental factors
Eﬃcient analysis of genetic eﬀects and their interactions with
environment is of great importance
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Single nucleotide polymorphism (SNP, pronounced as “snip”) is a
single nucleotide (A, T, C, or G) variation of the DNA sequence that
occurs in at least 1% of the population.
Example: C-T SNP
DNA fragment of subject 1: AAGCCTA
DNA fragment of subject 2: AAGCTTA
C and T are alleles, alternative forms of a DNA segment at a single
locus. One of these alleles is common, another one is rare
Subjects’ genetic information is described by SNP genotypes, e.g.
CC, CT, or TT
Standard categorical methods can be used to test for association
between a disease and a SNP genotype under various genetic models
(additive, dominant, recessive, etc.)
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Consider a subset of case-control lung-cancer data of current and
former smokers from Amos et al. (2008)
9 SNPs, variables snp1-snp9, spanning the interval between
rs8034191 and rs8192475
Other characteristics: cancer, female, smkformer, packyrs
Two SNPs, rs8034191 (snp1) and rs1051730 (snp8), in a region of
15q25.1 containing nicotinic acetylcholine receptors genes are
signiﬁcantly associated with risk of lung cancer
Data summary:
Characteristic Cases Controls
Sex (% female) 42.98 43.36
Former smokers (%) 52.25 57.78
Pack years (s.d.) 51.49 (31.41) 44.57 (30.16)
Total 1154 1137
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separately for each SNP of interest:
. tabodds cancer snp1, or
snp1 Odds Ratio chi2 P>chi2 [95% Conf. Interval]
AA 1.000000 . . . .
AG 1.188315 3.65 0.0561 0.995320 1.418732
GG 1.811803 20.08 0.0000 1.391670 2.358770
Test of homogeneity (equal odds): chi2(2) = 20.16
Pr>chi2 = 0.0000
Score test for trend of odds: chi2(1) = 18.34
Pr>chi2 = 0.0000
. tabodds cancer snp8, or
snp8 Odds Ratio chi2 P>chi2 [95% Conf. Interval]
GG 1.000000 . . . .
AG 1.250974 6.15 0.0132 1.047655 1.493752
AA 1.777132 18.92 0.0000 1.366588 2.311010
Test of homogeneity (equal odds): chi2(2) = 19.83
Pr>chi2 = 0.0000
Score test for trend of odds: chi2(1) = 19.37
Pr>chi2 = 0.0000
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Single SNP analysis may have low power to detect genetic eﬀects
(Akey et al. 2001, de Bakker et al. 2005)
Alternative: analyze multiple SNPs simultaneously via haplotypes
Humans’ genetic information is comprised of diplotypes
In practice, we usually observe genotypes (the sums of two
haplotypes) rather than diplotypes
Example: 2 SNPs (binary notation: 0 is common allele, 1 is rare
allele)
4 possible haplotypes: 00, 01, 10, 11
16 possible diplotypes: (00,00), (00,01),..., (11,10), (11,11)
9 possible genotypes: 00, 01, 02, 10, 11, 12, 20, 21, 22
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Let’s now analyze two SNPs of interest simultaneously using
haplologit (Marchenko et al. 2008)
Major (reference) and minor alleles are coded as 0 and 1, respectively
A is a reference allele for snp1, G is a reference allele for snp8
. haplologit cancer, snp(snp1 snp8)
Handling missing SNPs:
Building consistent haplotype pairs:
Obtaining initial haplotype frequency estimates from the control sample:
Haplotype frequency EM estimation under HWE
Number of iterations = 8






* frequencies > .001
(Continued on next page)
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note: using the most frequent haplotype from the control sample as a risk haplotype
Haplotype-effects logistic regression
Mode of inheritance: additive Number of obs = 2291
Genetic distribution: Hardy-Weinberg equilib. Number phased = 1289
Genotype: snp1 snp8 Number unphased = 1000
Number missing = 2
Wald chi2(1) = 18.47
Retrospective log likelihood = -2746.8085 Prob > chi2 = 0.0000
cancer Coef. Std. Err. z P>|z| [95% Conf. Interval]
hap_00 -0.263 0.061 -4.30 0.000 -0.382 -0.143
Haplotype Frequencies Estimate Std. Err. [95% Conf. Interval]
hap_00 .652029 .0099915 .632446 .671612
hap_01 .0105619 .0014741 .0076727 .0134512
hap_10 .011765 .0015559 .0087154 .0148146
hap_11 .325644 .0095724 .3068825 .3444055
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eﬀects of all other haplotypes:
. haplologit cancer, snp(snp1 snp8) riskhap1("11") riskhap2("10") riskhap3("01") noemshow
Handling missing SNPs:
Building consistent haplotype pairs:
Obtaining initial haplotype frequency estimates from the control sample:
Performing gradient-based optimization:
Haplotype-effects logistic regression
Mode of inheritance: additive Number of obs = 2291
Genetic distribution: Hardy-Weinberg equilib. Number phased = 1289
Genotype: snp1 snp8 Number unphased = 1000
Number missing = 2
Wald chi2(3) = 19.51
Retrospective log likelihood = -2746.2814 Prob > chi2 = 0.0002
cancer Coef. Std. Err. z P>|z| [95% Conf. Interval]
hap_11 0.275 0.062 4.40 0.000 0.152 0.397
hap_10 0.017 0.266 0.06 0.949 -0.503 0.537
hap_01 0.161 0.280 0.58 0.565 -0.388 0.710
Haplotype Frequencies Estimate Std. Err. [95% Conf. Interval]
hap_00 .6520033 .0099923 .6324187 .6715878
hap_01 .0111454 .002217 .0068002 .0154905
hap_10 .0133441 .0024204 .0086003 .018088
hap_11 .3235072 .0098137 .3042727 .3427417Why use haplologit?
haplologit allows joint estimation of multiple SNPs via haplotypes
and, thus, can be more powerful in detecting genetic associations
haplologit accounts for retrospective sampling design and, thus, is
more appropriate for the analysis of case-control data
haplologit can be more eﬃcient than standard prospective logistic
regression under the assumptions of Hardy-Weinberg equilibrium
(HWE) and independence between haplotypes and environmental
factors
haplologit handles unphased and missing genotypes
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haplologit ﬁts haplotype-based logistic regression to case-control data
and estimates the eﬀects of haplotypes of interest on the disease and,
optionally, their interactions with environmental factors using eﬃcient
semiparametric method of Spinka et al. (2005) and Lin and Zeng (2006)
which
accounts for retrospective sampling design
incorporates phase uncertainty
handles missing genotypes
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1 Z1 + γ2IH⋆
1 Z2 + ...
βs are haplotype main eﬀects, γs are haplotype-environment
interaction eﬀects
Z are environmental covariates, G are observed genotypes
IH⋆
i s are genetic covariates, which are determined by a chosen genetic
model and depend on the number of copies of a risk haplotype H⋆
i in
observed genotypes G (or, more speciﬁcally, corresponding
diplotypes).
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Select cases (D = 1) and sample from them to obtain values of
genotypes G and covariates Z
Select controls (D = 0) and sample from them to obtain values of
genotypes G and covariates Z




Standard logistic regression (ignoring retrospective design) is
semiparametric-eﬃcient when covariate distribution f (Z,G) is
unrestricted (Breslow et al. 2000)
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associated with genetic data:
a) population in Hardy-Weinberg equilibrium
q{(Hk,Hl);θ} = θ2
k if Hk = Hl
= 2θkθl if Hk  = Hl
θk denotes the frequency for haplotype Hk.
b) gene-environment independence – f (Z,G) = g(Z)q(G)
To handle unphased and missing genotypes, we need to impose
restrictions on the genetic distribution (such as HWE or certain
deviations from it)
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Genotypes G are assumed to be missing at random
Keeping in mind binary notation, missing components of G may be
any value from {0,1,2} resulting in multiple plausible diplotypes for a
subject with incomplete genetic information
Missing genotypes are handled by “averaging” the likelihood over all
such constituent diplotypes for each subject
Accommodation of missing genotypes requires distributional
assumptions (e.g., HWE) for the genetic data
Yulia Marchenko (StataCorp) Haplotype analysis of case-control data September 9, 2010 16 / 41Unphased genotypes
Consider 2 SNP genotypes AG and CT of a subject
Two diplotypes are consistent with the observed genotype: (AC, GT)
and (AT, GC)
Thus, phase is indeterminant (ambiguous) for this subject
More generally, phase ambiguity arises for heterozygous subjects who
carry diﬀerent alleles at two or more SNP loci
Phase ambiguity can be viewed as a missing-data problem and is
handled similarly
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Marchenko et al. (2008) presented the haplologit command for
haplotype analysis of case-control genetic data in the important special
case of
a rare disease
a single candidate gene in HWE
gene-environment independence
The command also supported a number of genetic models, such as
additive, recessive, and dominant.
New capabilities include:
relaxing the assumption of HWE
extending the catalogue of genetic models to include codominant
models
genome-wide association analysis
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relaxing the assumption of HWE:
q{(Hk,Hl);θ} = θ2
k + ρθk(1 − θk) if Hk = Hl
= (1 − ρ)θkθl if Hk  = Hl
where ρ denotes the inbreeding coeﬃcient.
codominant models:
homozygous/heterozygous model — the eﬀect of having two copies of
a rare haplotype is allowed to be diﬀerent from the eﬀect of having
only one copy
additive/recessive model — the eﬀect of a rare haplotype is
decomposed into two separate components, additive and recessive,
allowing to test if the eﬀects are additive, recessive, or dominant
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. haplologit cancer, snp(snp1 snp8) riskhap1("11") hwd
Handling missing SNPs:
Building consistent haplotype pairs:
Obtaining initial haplotype frequency estimates from the control sample:
Haplotype frequency EM estimation under HWD
Number of iterations = 175






* frequencies > .001
Inbreeding rho = .000023
(Continued on next page)
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Iteration 0: Retrospective log likelihood = -2766.2715
Iteration 1: Retrospective log likelihood = -2746.4871
Iteration 2: Retrospective log likelihood = -2746.4482
Iteration 3: Retrospective log likelihood = -2746.4482
Haplotype-effects logistic regression
Mode of inheritance: additive Number of obs = 2291
Genetic distribution: Hardy-Weinberg disequil. Number phased = 1289
Genotype: snp1 snp8 Number unphased = 1000
Number missing = 2
Wald chi2(1) = 19.17
Retrospective log likelihood = -2746.4482 Prob > chi2 = 0.0000
cancer Coef. Std. Err. z P>|z| [95% Conf. Interval]
hap_11 .2713723 .0619759 4.38 0.000 .1499017 .3928429
Haplotype Frequencies Estimate Std. Err. [95% Conf. Interval]
hap_00 .6510113 .0097365 .6319281 .6700946
hap_01 .0120607 .0016671 .0087932 .0153282
hap_10 .0134345 .0017577 .0099896 .0168795
hap_11 .3234934 .0098139 .3042586 .3427282
rho 4.02e-08 . . .
Yulia Marchenko (StataCorp) Haplotype analysis of case-control data September 9, 2010 21 / 41Codominant model: hetero/homo-zygous eﬀects
. haplologit cancer, snp(snp1 snp8) riskhap1("11") inheritance(codominant) or
Haplotype-effects logistic regression
Mode of inheritance: type I codominant Number of obs = 2291
Genetic distribution: Hardy-Weinberg equilib. Number phased = 1289
Genotype: snp1 snp8 Number unphased = 1000
Number missing = 2
Wald chi2(2) = 20.97
Retrospective log likelihood = -2745.75 Prob > chi2 = 0.0000
cancer Odds Ratio Std. Err. z P>|z| [95% Conf. Interval]
hap_11
heteroz. 1.239025 .0972226 2.73 0.006 1.062402 1.445011
homoz. 1.777553 .223547 4.57 0.000 1.389231 2.27442
Haplotype Frequencies Estimate Std. Err. [95% Conf. Interval]
hap_00 .6510032 .0097367 .6319196 .6700867
hap_01 .0120649 .0016677 .0087963 .0153334
hap_10 .0134386 .0017582 .0099927 .0168846
hap_11 .3234933 .0098139 .3042585 .3427281
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. haplologit cancer packyrs, snp(snp1 snp8) riskhap1("11", inter(packyrs))
> inheritance(codominant) or
Haplotype-effects logistic regression
Mode of inheritance: type I codominant Number of obs = 2291
Genetic distribution: Hardy-Weinberg equilib. Number phased = 1289
Genotype: snp1 snp8 Number unphased = 1000
Number missing = 2
Wald chi2(5) = 52.42
Retrosp. profile log likelihood = -4318.1426 Prob > chi2 = 0.0000
cancer Odds Ratio Std. Err. z P>|z| [95% Conf. Interval]
packyrs 1.006844 .0018279 3.76 0.000 1.003268 1.010433
hap_11
heteroz. 1.235895 .1580349 1.66 0.098 .9619177 1.587909
homoz. 1.478571 .2756675 2.10 0.036 1.025989 2.130796
hap_11Xpac~s
heteroz. 1.00005 .0019853 0.03 0.980 .9961662 1.003948
homoz. 1.003496 .002579 1.36 0.175 .9984536 1.008563
Note: _cons = b0 + ln(N1/N0) - ln{Pr(D=1)/Pr(D=0)}
Haplotype Frequencies Estimate Std. Err. [95% Conf. Interval]
hap_00 .6510032 .0097367 .6319196 .6700867
hap_01 .0120649 .0016677 .0087963 .0153334
hap_10 .0134386 .0017582 .0099927 .0168846
hap_11 .3234933 .0098139 .3042585 .3427281Consider all 9 SNPs:
. haplologit cancer, snp(snp1-snp9) riskhap1(158) riskhap2(161) riskhap3(320)
> riskhap4(448)
Haplotype frequency EM estimation under HWE
Number of iterations = 52






















* frequencies > .001Performing gradient-based optimization:
note: removing 27 observations; constituent haplotype frequencies are
smaller than .001
Iteration 0: Retrospective log likelihood = -6690.1467
Iteration 1: Retrospective log likelihood = -6658.5547
Iteration 2: Retrospective log likelihood = -6658.1273
Iteration 3: Retrospective log likelihood = -6658.1259
Iteration 4: Retrospective log likelihood = -6658.1259
Haplotype-effects logistic regression
Mode of inheritance: additive Number of obs = 2264
Genetic distribution: Hardy-Weinberg equilib. Number phased = 687
Genotype: snp1 snp2 snp3 snp4 snp5 Number unphased = 1546
snp6 snp7 snp8 snp9 Number missing = 31
Wald chi2(4) = 28.60
Retrospective log likelihood = -6658.1259 Prob > chi2 = 0.0000
cancer Coef. Std. Err. z P>|z| [95% Conf. Interval]
ha~010011101 -0.470 0.249 -1.89 0.059 -0.958 0.018
ha~010100000 0.267 0.141 1.89 0.058 -0.009 0.542
ha~100111111 0.196 0.101 1.95 0.051 -0.001 0.394
ha~110111111 0.323 0.071 4.54 0.000 0.184 0.463
(output omitted)
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Our earlier example included 9 SNPs comprising a small DNA region,
variations in which were statistically associated with the increased risk
of lung cancer
There are about 10 million common SNPs which make up about 90%
of variations in human genome
The International HapMap Consortium (2007) provides over 3.1
million SNPs accounting for about 35% of common SNP variation in
human genome
Can’t we somehow use the information available in the whole genome
to identify various regions of DNA which could be associated with a
disease?
One way is to perform genome-wide association analysis (e.g., Risch
and Merikangas 1996)
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Objective: ﬁnd genetic variations across the whole genome associated
with a disease
Challenge: computationally infeasible to analyze even hundreds of
SNPs simultaneously
Solution: use sliding window approach (e.g., de Bakker et al. 2005)
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Arrange all SNPs of interest into blocks of a particular size
Each block of SNPs determines a “window” and the number of SNPs
in each block determines the window size
Test for association within each window to obtain multiple observed
signiﬁcance levels
Adjust observed signiﬁcance levels for multiple tests
Test statistics from adjacent windows are often correlated because of
overlapping windows or LD of the constituent SNPs
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Commonly used Bonferroni correction
Permutation method
k-FWER (family-wise error rate) method to control the probability of
k (≥ 1) or more false positives
In GWAS, test statistics from adjacent windows are often correlated
because of overlapping windows or linkage disequlibrium of the
constituent SNPs
A more powerful alternative for GWAS is a Monte Carlo (MC)
method of Huang et al. (2007)
The MC method is implemented in gwhaplologit, currently under
development
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Recall our lung-cancer example
We consider a version of the data containing 41 SNPs surrounding
the region containing two SNPs of interest: rs8034191 (snp21) and
rs1051730 (snp28)
We use gwhaplologit to investigate regions of associations with
lung cancer among these 41 SNPs
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. gwhaplologit cancer, snp(snp1-snp41) wsize(1)
Windows (41):
.........10.........20.........30.........40.
Genomewide association analysis Number of windows = 41
Haplotype-effects logistic regression overlap = 0
Mode of inheritance: additive Alpha (FWER) = .1
Genetic distribution: Hardy-Weinberg equil. Number of SNPs = 41
Haplotype model: main effects Number of obs = 2291
cases = 1154
controls = 1137
P-value, (k=1) Null model
Windows (1) Unadjusted k-FWER k-FWER-MC DF N LogL
1-1 0.6099 1.0000 0.9996 1 2291 -2223.7770
2-2 0.6103 1.0000 0.9994 1 2291 -2225.1633
3-3 0.5001 1.0000 0.9980 1 2291 -1644.2568
4-4 0.8618 1.0000 0.9820 1 2291 -2163.2535
5-5 0.8739 1.0000 0.8790 1 2291 -2346.2864
6-6 0.4828 1.0000 0.9988 1 2291 -1798.4522
7-7 0.0765 1.0000 0.7324 1 2291 -2145.5205
8-8 0.2867 1.0000 0.9904 1 2291 -2364.8668
9-9 0.6808 1.0000 0.9992 1 2291 -2243.6853
10-10 0.6667 1.0000 0.9996 1 2291 -2159.3543
11-11 0.8296 1.0000 0.9944 1 2291 -2326.8001
12-12 0.5014 1.0000 0.9964 1 2291 -2339.4497
13-13 0.7450 1.0000 0.9988 1 2291 -1777.9610
14-14 0.2801 1.0000 0.9926 1 2291 -2309.4833
(Continued on next page)15-15 0.0487 1.0000 0.6008 1 2291 -1709.3345
16-16* 0.0012 0.0479 0.0328 1 2291 -2148.8787
17-17 0.0222 0.9116 0.3800 1 2291 -2080.2937
18-18 0.0152 0.6223 0.2874 1 2291 -2367.9991
19-19 0.0929 1.0000 0.7880 1 2291 -2235.6978
20-20 0.6062 1.0000 0.9998 1 2291 -1583.0288
21-21* 0.0000 0.0007 0.0006 1 2291 -2278.9731
22-22 0.3541 1.0000 0.9954 1 2291 -1248.6997
23-23 0.0108 0.4429 0.2282 1 2291 -1753.2560
24-24 0.0226 0.9273 0.3752 1 2291 -2291.1795
25-25 0.1446 1.0000 0.9012 1 2291 -2339.4240
26-26 0.1211 1.0000 0.8686 1 2291 -2341.3457
27-27 0.0889 1.0000 0.7746 1 2291 -2337.5105
28-28* 0.0000 0.0004 0.0002 1 2291 -2279.8622
29-29 0.2888 1.0000 0.9878 1 2291 -788.1882
30-30* 0.0037 0.1504 0.0950 1 2291 -1742.0743
31-31 0.1362 1.0000 0.8892 1 2291 -2212.3007
32-32 0.0453 1.0000 0.5788 1 2291 -2238.4966
33-33 0.0363 1.0000 0.5154 1 2291 -1474.4632
34-34 0.4966 1.0000 0.9990 1 2291 -959.7251
35-35 0.0545 1.0000 0.6240 1 2291 -2353.6201
36-36 0.0503 1.0000 0.5970 1 2291 -2349.5156
37-37 0.1344 1.0000 0.8930 1 2291 -1581.0391
38-38 0.7942 1.0000 0.9978 1 2291 -2255.4285
39-39 0.0703 1.0000 0.7140 1 2291 -2347.9133
40-40 0.0756 1.0000 0.7366 1 2291 -2346.1990
41-41 0.3717 1.0000 0.9924 1 2291 -1934.6021
(obs. with constituent haplotypes with frequencies smaller than .001 omitted)
(haplotypes with freq. smaller than .002182 plus most frequent used as reference)
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. gwhaplologit cancer, snp(snp1-snp41) wsize(2) overlap(1) significant
Windows (40):
.........10.........20.........30.........40
Genomewide association analysis Number of windows = 40
Haplotype-effects logistic regression overlap = 1
Mode of inheritance: additive Alpha (FWER) = .1
Genetic distribution: Hardy-Weinberg equil. Number of SNPs = 41
Haplotype model: main effects Number of obs = 2291
cases = 1154
controls = 1137
P-value, (k=1) Null model
Windows (2) Unadjusted k-FWER k-FWER-MC DF N LogL
15-16* 0.0031 0.1228 0.0576 2 2289 -3691.7850
16-17* 0.0032 0.1261 0.0584 2 2289 -3904.8767
18-19* 0.0017 0.0663 0.0346 3 2291 -4603.6833
20-21* 0.0003 0.0119 0.0072 3 2291 -3794.7572
21-22* 0.0000 0.0013 0.0012 2 2287 -3175.5475
23-24* 0.0001 0.0039 0.0022 2 2289 -3794.9488
27-28* 0.0000 0.0009 0.0006 2 2291 -3860.3080
28-29* 0.0000 0.0005 0.0006 2 2291 -3021.2687
30-31* 0.0003 0.0139 0.0084 2 2290 -3748.7077
32-33* 0.0017 0.0692 0.0350 3 2291 -3627.4546
(obs. with constituent haplotypes with frequencies smaller than .001 omitted)
(haplotypes with freq. smaller than .002182 plus most frequent used as reference)
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association for lung-cancer data from gwhaplologit for varying






































































Relax gene-environment independence assumption
Allow multiple genes and gene-gene interactions
Handle untyped SNPs
Accommodate population stratiﬁcation
Accommodate association tests including interaction eﬀects in GWAS
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